AUPP915099A0 - Improved composition for oral administration - Google Patents
Improved composition for oral administrationInfo
- Publication number
- AUPP915099A0 AUPP915099A0 AUPP9150A AUPP915099A AUPP915099A0 AU PP915099 A0 AUPP915099 A0 AU PP915099A0 AU PP9150 A AUPP9150 A AU PP9150A AU PP915099 A AUPP915099 A AU PP915099A AU PP915099 A0 AUPP915099 A0 AU PP915099A0
- Authority
- AU
- Australia
- Prior art keywords
- oral administration
- improved composition
- composition
- improved
- oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPP9150A AUPP915099A0 (en) | 1999-03-12 | 1999-03-12 | Improved composition for oral administration |
PCT/AU2000/000175 WO2000054812A1 (en) | 1999-03-12 | 2000-03-13 | Improved composition for oral administration |
AU31339/00A AU3133900A (en) | 1999-03-12 | 2000-03-13 | Improved composition for oral administration |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPP9150A AUPP915099A0 (en) | 1999-03-12 | 1999-03-12 | Improved composition for oral administration |
Publications (1)
Publication Number | Publication Date |
---|---|
AUPP915099A0 true AUPP915099A0 (en) | 1999-04-15 |
Family
ID=3813349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AUPP9150A Abandoned AUPP915099A0 (en) | 1999-03-12 | 1999-03-12 | Improved composition for oral administration |
Country Status (2)
Country | Link |
---|---|
AU (1) | AUPP915099A0 (en) |
WO (1) | WO2000054812A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA026670B1 (en) * | 2006-03-10 | 2017-05-31 | Лабосвисс Аг | Method for solubilizing, dispersing, and stabilizing materials, products manufactured according to said method, and use thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4753800A (en) * | 1985-10-04 | 1988-06-28 | Warner-Lambert Company | Medicament adsorbates and their preparation |
US4948580A (en) * | 1988-12-08 | 1990-08-14 | E. R. Squibb & Sons, Inc. | Muco-bioadhesive composition |
US5112604A (en) * | 1989-09-01 | 1992-05-12 | Riker Laboratories, Inc. | Oral suspension formulation |
WO1999016454A1 (en) * | 1997-09-26 | 1999-04-08 | Medeva Europe Limited | Pharmaceutical composition for the treatment of inflammatory bowel disease |
-
1999
- 1999-03-12 AU AUPP9150A patent/AUPP915099A0/en not_active Abandoned
-
2000
- 2000-03-13 WO PCT/AU2000/000175 patent/WO2000054812A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2000054812A1 (en) | 2000-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2276801A (en) | Extended release oral dosage composition | |
AU2277101A (en) | Stable extended release oral dosage composition | |
AU3192700A (en) | Medicinal compositions | |
AU2115301A (en) | Dental compositions | |
AU6089200A (en) | Rapid immediate release oral dosage form | |
AU3556400A (en) | Pharmaceutical compositions | |
AU2005300A (en) | Medicinal compositions | |
AU4143999A (en) | Oral composition comprising capsules | |
AU1887401A (en) | Medicinal composition | |
AU4428000A (en) | Pulse-delivery oral compositions | |
AU2001284444A1 (en) | Preparations for oral administration | |
AU1735001A (en) | Cyclodextrin-containing pharmaceutical composition | |
AU6715600A (en) | Pharmaceutical formulations | |
AU5838398A (en) | Rapamycin formulations for oral administration | |
AU2564399A (en) | Isoflavanoid formulations for oral administration | |
AU4304400A (en) | Novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives | |
AU5460800A (en) | Pharmaceutical transdermal compositions | |
AU6460400A (en) | Pharmaceutical compositions | |
AU1732401A (en) | Medicinal compositions for oral use | |
AU7735798A (en) | Pharmaceutical composition for oral administration | |
AU4977300A (en) | Pharmaceutical formulations | |
AU6460200A (en) | Pharmaceutical compositions | |
AU1385801A (en) | Pharmaceutical formulations | |
AU3322000A (en) | Oral anti-odor compositions | |
AU6460100A (en) | Pharmaceutical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAA1 | Application designating australia and claiming priority from australian document |
Ref document number: 3133900 Country of ref document: AU |